Contact us
855-415-3472
Schedule a Demo

CPT Code 43238 Complete Billing & Coding Guide for EGD with EUS-Guided Fine Needle Aspiration

best medical billing company

Seamless Global Period Tracking and Compliance

Accurate OB Contract Management and Patient Collections

Precise coding plays a key role in gastroenterology medical billing and coding to attain compliance, maximize reimbursement and reduce audit risk. Advanced EUS-guided procedures require both proper code selection, thorough FNA documentation, and distinguishing between limited and full EUS services, to achieve claim accuracy. Failure to report all lesion characteristics, needle technique or anatomical extent may result in denials and revenue delays. 

This guide includes key billing requirements, documentation, and coding considerations per most recent CMS and AACP guidelines to facilitate clean claims and predictable reimbursement results.  

CPT 43238 – Description

Official Definition: “Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s), (includes endoscopic ultrasound examination limited to the esophagus, stomach or duodenum, and adjacent structures).”

This code describes an advanced upper GI endoscopy in which the physician uses a specialized echoendoscope to perform an ultrasound examination and then guides a fine needle through the wall of the esophagus, stomach, or duodenum to sample a target lesion in the wall layers or in adjacent structures such as lymph nodes or periluminal masses.

CPT 43238 includes the code EUS examination (43237) within the needle aspiration. The EUS component cannot be billed separately as the limited EUS examination is explicitly stated in the descriptor. The code addresses the entire process, insertion of the scope, assessment of the EUS, deployment of the needle, tissue collection and post procedure evaluation. 

When to Use CPT 43238

Provider should use CPT 43238 when performing a fine needle aspiration or tissue biopsy in the esophagus, stomach, duodenum or areas directly adjacent to any of these structures during the same EGD session. 

Common clinical indications include:

  • Sampling of esophageal or gastric submucosal masses (GIST, leiomyoma, lymphoma).
  • Fine needle aspiration of periesophageal, peripancreatic peri-nodal, or perigastric lymph nodes for cancer staging.
  • Biopsy of mediastinal or subcarinal nodes reachable from the esophagus.
  • Sampling of small bowel wall or duodenal lesions not accessible by standard biopsy forceps.
  • Evaluation of suspicious findings in adjacent structures identified on prior imaging.

Do not report 43238 for:

  • Without FNA or biopsy (use 43237).
  • Snare biopsy or standard forceps of the mucosal layer (use 43239).
  • EUS-guided FNA of the pancreas, bile ducts, or liver (use 43242 when the structure is long
  • Esophagoscopy with EUS-guided FNA limited to the esophagus (use 43232).
  • EUS-guided therapeutic drainage or injection procedures (use 43240 or 43236, respectively).

Reimbursement and Billing Insights For CPT Code 43238

This advanced EUS-guided procedure is reimbursed based on its increased complexity as it integrates real time imaging with tissue sampling. It is paid depending on the site of service, payer policies and locality corrections and, therefore, the specific sums vary by region and contract. 

Key reimbursement components:

  • Physician payment (facility setting): According to work RVUs and adjusted yearly according to the Medicare Physician Fee Schedule.
  • Facility payment (hospital/ASC):Billed as an outpatient or ASC payment system.
  • Work RVU: More expensive than diagnostic EGD because of the additional FNA component. 
  • Global period: 0 days (no post-op package included)

Important reimbursement considerations:

  • This procedure typically reimburses higher than diagnostic EGD and limited EUS alone
  • Site-of-service differential has the overall effect of affecting payment distribution between provider and facility. 
  • Moderate sedation (G0500) is separately reportable when applicable
  • Cytopathology services (e.g., ROSE) may be billed independently by pathology
  • The commercial payer reimbursement can be variable and it might need prior authorization. 

Regular reimbursement relies on proper code assignment, full documentation of FNA, and compliance with billing requirements of payers, particularly to differentiate between limited and full EUS-guided procedures. 

Applicable Modifiers For CPT Code 43238

Modifiers assist in clarifying the billing situations: 

  • Modifier 22 – Increased procedural services when the EUS-FNA was significantly more complex than usual; supporting documentation required.
  • Modifier 52 – Reduced services when the target could not be reached or the planned sampling was only partially completed.
  • Modifier 53 – Discontinued procedure due to patient-related complications before completion.
  • Modifier 59 or XS – Used when a distinct biopsy (43239) is performed at a clearly separate site from the EUS-FNA target; documentation must support distinct anatomic sites.
  • Modifier 74 – Discontinued outpatient procedure after anesthesia administration (ASC/hospital outpatient use).
  • Modifier 51 – Multiple procedures when 43238 is performed with another unrelated procedure on the same day.

Component modifiers (26/TC) do not apply to 43238 as it is a global surgical code that includes both the endoscopic and ultrasound work. Always confirm payer-specific modifier acceptance before submission.

Documentation Requirements For CPT Code 43238

Medical necessity can be documented accurately and this prevents denials. Procedure notes must contain: 

  • Clinical indication and ICD-10 diagnosis supporting the LCD.
  • Pre-procedure consent and sedation plan and vital signs. 
  • Scope type (echoendoscope), route (transoral), and extent reached.
  • EUS findings including target lesion location, size, echogenicity, and wall-layer involvement.
  • Type and gauge of needle (e.g. 22G FNA needle). 
  • Number of needle passes and target confirmation.
  • Whether the approach was intramural or transmural.
  • Rapid on-site cytology evaluation (ROSE) findings if performed.
  • Saved ultrasound images and interpretation. 
  • Sedation time and medications, including independent observer where needed to meet Medicare requirements. 
  • Post-procedure status, complications and recovery notes. 
  • Signed procedure report by the performing gastroenterologist.

Example Scenarios For CPT Code 43238

  • Scenario 1: A gastroenterologist carries out EGD with EUS-guided FNA of a perilesophageal lymph node to stage a cancer. → Report CPT 43238.
  • Scenario 2: EUS-FNA of a mass in the gastric submucosa with three needle injections and on-site cytology. → Report CPT 43238 plus 88172 and 88173 of services with cytology. 
  • Scenario 3: EUS-FNA of pancreatic body mass due to case of suspected adenocarcinoma. → Do not report 43238; report 43242 since the target is outside the esophagus/stomach/duodenum limits. 
  • Scenario 4: EUS-FNA of an esophageal mass plus forceps biopsy of a separate duodenal ulcer. → Report 43238 and 43239-59 (distinct sites documented).

BillingFreedom Delivers 98%+ Claim Accuracy with <1% Denials in Advanced EUS Billing

Managing complex EUS-guided procedures in gastroenterology medical billing and coding requires strong alignment between clinical documentation, coding accuracy, and payer rules. BillingFreedom consistently maintains 98%+ first-pass claim accuracy with denial rates below 1%, helping practices improve performance in gastroenterology medical billing through cleaner claims and reduced administrative rework.

The team applies detailed expertise in advanced endoscopy billing, including correct differentiation between limited and full EUS-FNA, accurate cytopathology code pairing, and strict adherence to once-per-session billing rules. Every claim is reviewed against payer-specific policies, LCD requirements, and authorization protocols before submission.

Key capabilities include:

  • Accurate code selection based on procedure complexity
  • Detailed documentation review for lesion and FNA specifics
  • Bundling and modifier control to prevent coding conflicts
  • Pre-authorization verification for advanced procedures
  • Denial prevention checks before claim submission

This structured approach supports faster reimbursements, reduced denials, and improved revenue cycle performance, while ensuring full compliance with evolving standards in gastroenterology medical billing.

For more details about our exceptional Gastroenterology medical billing services, please don't hesitate to contact us via email at info@billingfreedom.com or call us at +1 (855) 415-3472. 

Your financial tranquility is our priority!

Related ICD-10-CM Codes

ICD-10-CM Codes

Related CPT Codes

CPT Codes